- Home
- SGRP vs NRSN Comparison
SGRP vs NRSN Comparison
Compare SGRP & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGRP
- NRSN
- Stock Information
- Founded
- SGRP 1967
- NRSN 2017
- Country
- SGRP United States
- NRSN Israel
- Employees
- SGRP N/A
- NRSN N/A
- Industry
- SGRP Business Services
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- SGRP Consumer Discretionary
- NRSN Health Care
- Exchange
- SGRP Nasdaq
- NRSN Nasdaq
- Market Cap
- SGRP 25.2M
- NRSN 29.8M
- IPO Year
- SGRP 1996
- NRSN 2021
- Fundamental
- Price
- SGRP $1.06
- NRSN $1.18
- Analyst Decision
- SGRP
- NRSN Buy
- Analyst Count
- SGRP 0
- NRSN 2
- Target Price
- SGRP N/A
- NRSN $14.00
- AVG Volume (30 Days)
- SGRP 34.2K
- NRSN 243.1K
- Earning Date
- SGRP 11-13-2025
- NRSN 11-03-2025
- Dividend Yield
- SGRP N/A
- NRSN N/A
- EPS Growth
- SGRP N/A
- NRSN N/A
- EPS
- SGRP N/A
- NRSN N/A
- Revenue
- SGRP $143,501,000.00
- NRSN N/A
- Revenue This Year
- SGRP $7.22
- NRSN N/A
- Revenue Next Year
- SGRP N/A
- NRSN N/A
- P/E Ratio
- SGRP N/A
- NRSN N/A
- Revenue Growth
- SGRP N/A
- NRSN N/A
- 52 Week Low
- SGRP $0.91
- NRSN $0.80
- 52 Week High
- SGRP $2.48
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- SGRP 49.90
- NRSN 44.09
- Support Level
- SGRP $1.02
- NRSN $1.15
- Resistance Level
- SGRP $1.08
- NRSN $1.30
- Average True Range (ATR)
- SGRP 0.03
- NRSN 0.07
- MACD
- SGRP 0.01
- NRSN -0.00
- Stochastic Oscillator
- SGRP 73.33
- NRSN 31.43
About SGRP SPAR Group Inc.
SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.